| 标题 |
Atorvastatin safety and pharmacokinetics in acute kawasaki disease patients with coronary artery abnormalities
阿托伐他汀在急性川崎病冠状动脉异常患者中的安全性和药代动力学
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | Introduction: Despite therapy with intravenous immunoglobulin, 25% of children with Kawasaki disease (KD) develop coronary artery abnormalities (CAA) and endothelial cell (EC) dysfunction. Based on the pleiotropic effects of statins on restoring EC homeostasis, we performed a Phase I clinical trial of atorvastatin for acute KD patients with early CAA. Hypothesis: A sixweek (wk) course of atorvastatin in acute KD patients (pts) with CAA will be safe, welltolerated and restore EC homeostasis. Methods: This twocenter, Phase I, open label, dose escalation trial enrolled acute KD subjects aged 217 years with an initial CA Z score ≥ 2.5 in a 6wk study of atorvastatin (0.125, 0.25, 0.5 and 0.75 mg/kg/day). Demographic, clinical and laboratory data, and echo core lab readings were collected at baseline, |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
浮游
哆啦的空间站
毛豆
不配.
zcl
小青椒
Zx_1993
朝阳区李知恩
有结果
馆长
wop111
雨0926
柴桑青木
eric888
Hilda007
彭于彦祖
64658
Criminology34
个性的紫菜
子车茗
打工小房
LaTeXer
yznfly
tuanheqi
无极微光
caizhonglun
Dean
DijiaXu
皖公网安备34019202002308
